The following are cytogenetic abnormalities that are considered as presumptive evidence of MDS in the setting of persistent cytopenias:
|
-7 or del (7q)
|
-5 or del(5q)
|
|
i(17q) or t(17p)
|
-13 or del(13q)
|
|
del(11q)
|
del(12p) or t(12p)
|
|
del(9q)
|
idic(X)(q13)
|
|
t(11;16)(q23;p13.3)
|
t(3;21)(q26.2;q22.1)
|
|
t(1;3)(p36.3;q21.2)
|
t(2;11)p21;q23)
|
|
inv(3)(q21q26.2)
|
t(6;9)(p23;q34)
|
References
Weinzierl EP, Arber DA. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. Am J Clin Pathol. 2012;139: 9–29. doi:10.1309/AJCP50AEEYGREWUZ
BrunningRD,OraziA,GermingU,etal.Myelodysplasticsyndromes/neoplasms: overview. In: Swerdlow S, CampoE, Harris NL, et al, eds.WHO Classification of Tumors ofHaematopoietic and Lymphoid Tissues. 4th ed. Lyon, France:IARC Press; 2008.